Graticule Asia Macro Advisors’s Regenxbio RGNX Stock Holding History

Graticule Asia Macro Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-24,680	Closed	-$487K	–	120
2017 Q2	$487K	Sell	24,680 -24,470	-50%	-$474K	0.02%	107
2017 Q1	$949K	Hold	49,150	–	–	0.06%	107
2016 Q4	$912K	Sell	49,150 -18,350	-27%	-$351K	0.11%	86
2016 Q3	$946K	Buy	67,500 +26,000	+63%	+$287K	0.07%	85
2016 Q2	$332K	Buy	+41,500	New	+$461K	0.03%	48
2016 Q1	–	Sell	-39,800	Closed	-$662K	–	163
2015 Q4	$662K	Sell	39,800 -228,200	-85%	-$4.53M	0.11%	153
2015 Q3	$5.91M	Buy	+268,000	New	+$6.84M	0.69%	25

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Graticule Asia Macro Advisors's RGNX Position: Q3 2017 in Review

Graticule Asia Macro Advisors sold out of Regenxbio (RGNX) in Q3 2017, closing a stake of 24,680 shares — an estimated $487K sold.

Graticule Asia Macro Advisors first reported a position in RGNX in Q3 2015 and held it in 7 quarters. The position peaked at $5.91M in Q3 2015. 89 funds tracked by Wall St. Rank hold RGNX as of Q3 2017.

Graticule Asia Macro Advisors reported no remaining Regenxbio position as of Q3 2017 after selling out during the quarter.
Graticule Asia Macro Advisors sold 24,680 Regenxbio shares in Q3 2017, an estimated $487K.
Graticule Asia Macro Advisors first reported a position in Regenxbio in Q3 2015 and held it in 7 quarters.
Graticule Asia Macro Advisors's Regenxbio position peaked at $5.91M in Q3 2015.
89 funds tracked by Wall St. Rank held Regenxbio as of Q3 2017.

Based on Graticule Asia Macro Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.